Update on Thyroid Cancer

 

 Buy Article Permissions and Reprints

Abstract

With over 2 000 articles published on thyroid cancer between January 1, 2006 and September 10, 2007 it is difficult to offer an updated and complete review on this malignancy. Thus, I elected to summarize papers published in 2007 on topics frequently overlooked in other reviews or books, and papers that are likely to be followed by interesting developments. Papers include: 1) the accuracy and currency of websites on thyroid cancer; 2) the detection of the V600E BRAF mutation in very small papillary thyroid cancers that are detected histologically; 3) the relationship between thyroid cancer and Hashimoto's thyroiditis or hepatitis C virus, an association that appears to be nonrandom; 4) the not negligible frequency of coexistence of thyroid cancer with primary hyperparathyroidism; 5) the value of ultrasound elastography of thyroid nodules in distinguishing malignant form benign lesions; 6) the value of percutaneous ethanol injection in the treatment of thyroid or nodal recurrences of thyroid cancer; 7) the relatively benign course of intrathyroid metastases from renal cell carcinoma; 8) the exceedingly rare thyroid paraganglioma, though the rate of reports has increased recently; and 9) the increase in serum calcitonin caused by chronic alcoholism, an increase that cannot be reversed by three weeks of alcohol weaning.

References

• 1 Sarlis NJ, Benvenga S. Molecular signalling in thyroid cancer. In: Farid NR (ed). Molecular basis of thyroid cancer. Boston: Kluwer Academic Publishers 2004: 237-264
  Google Scholar
• 2 Air M, Roman SA, Yeo H. et al . Outdated and incomplete: a review of thyroid cancer on the world wide web.  Thyroid. 2007;  17 259-265
  CrossrefPubMedGoogle Scholar
• 3 American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi. . Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules.  Endocr Pract. 2006;  12 63-102
  PubMedGoogle Scholar
• 4 Eysenbach G, Jadad AR. Evidence-based patient choice and consumer health informatics in the Internet age.  J Med Internet Res. 2001;  3 e19
  PubMedGoogle Scholar
• 5 Singer PA, Cooper DS, Daniels GH. et al . Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer.  Arch Intern Med. 1996;  156 2165-2172
  PubMedGoogle Scholar
• 6 Cooper DS, Doherty GM, Haugen BR. et al . Management guidelines for patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task-force.  Thyroid. 2006;  16 109-142
  CrossrefPubMedGoogle Scholar
• 7 Ugolini C, Giannini R, Lupi C. et al . Presence of BRAF V600E in very early stages of papillary thyroid carcinoma.  Thyroid. 2007;  17 381-388
  CrossrefPubMedGoogle Scholar
• 8 Giannini R, Ugolini C, Lupi C. et al . The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinomas.  J Clin Endocrinol Metab. 2007;  92 3511-3516
  CrossrefPubMedGoogle Scholar
• 9 Sargent R, LiVolsi V, Murphy J, Mantha G, Hunt JL. BRAF mutation is unusual in chronic lymphocytic thyroiditis-associated papillary thyroid carcinomas and absent in non-neoplastic nuclear atypia of thyroiditis.  Endocr Pathol. 2006;  17 235-241
  CrossrefPubMedGoogle Scholar
• 10 Kim KH, Suh KS, Kang DW, Kang DY. Mutations of the BRAF gene in papillary thyroid carcinoma and Hashimoto's thyroiditis.  Pathol Int. 2005;  55 540-545
  CrossrefPubMedGoogle Scholar
• 11 Larson SD, Jackson LN, Riall TS. et al . Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroidi-tis and the role of the PI3/Akt pathway.  J Am Coll Surg. 2007;  207 764-773
  PubMedGoogle Scholar
• 12 Costanzo M, Caruso LA, Testa R, Marziani A, Cannizzaro MA. Hashimoto thyroiditis. Possible causes and consequence of a malignant thyroid tumor.  Ann Ital Chir. 2006;  77 469-471
  PubMedGoogle Scholar
• 13 Cipolla C, Sandonato L, Graceffa G. et al . Hashimoto thyroiditis coexistent with papillary thyroid cancer.  Am Surg. 2005;  71 874-878
  PubMedGoogle Scholar
• 14 Antonelli A, Ferri C, Fallahi P. et al . Thyroid cancer in HCV-related chronic hepatitic patients: a case-control study.  Thyroid. 2007;  17 447-451
  CrossrefPubMedGoogle Scholar
• 15 Rizzo M, Talamo Rossi R, Rosan A, Bonaffini O, Scisca C, La Torre F, Calbo L, Santarpia L, Benvenga S. 13th International Thyroid Congress, Buenos Aires, Argentina, October 30 to November 4, 2005.  In Thyroid. 2005;  15 ((Suppl 1)) S41/S42 , (Abstract 0-116)
  PubMedGoogle Scholar
• 16 Guarneri F, Benvenga S. Environmental factors and genetic background that interact to cause autoimmune thyroid disease.  Curr Opin Endocrinol Diab Obesity. 2007;  14 398-409
  PubMedGoogle Scholar
• 17 Antonelli A, Ferri C, Fallahi P. et al . Thyroid disorders in chronic hepatitis C virus infection.  Thyroid. 2006;  16 563-572
  CrossrefPubMedGoogle Scholar
• 18 Ogawa T, Kammori M, Tsui E-I. et al . Preoperative evaluation of thyroid pathology in patients with primary hyperparathyroidism.  Thyroid. 2007;  17 59-62
  CrossrefPubMedGoogle Scholar
• 19 Masatsugu T, Yamashita H, Noguchi S. et al . Thyroid evaluation in patients with primary hyperparathyroidism.  Endocrine J. 2005;  52 177-182
  PubMedGoogle Scholar
• 20 Schoretsianitis G, Taflampas P, Christodoulakis M, Peppe A, Tsiftis D. The significance of concomitant multinodular goiter in primary hyperparathyroidism.  79th American Thyroid Association, New York, October 03-07, 2007. Thyroid. 2007;  17 ((Suppl 1)) S-10 , (Abstract 181)
  PubMedGoogle Scholar
• 21 Morini E, Frisina N, Campennì A. et al . 79th American Thyroid Association, New York, October 03-07, 2007. Thyroid. 2007;  17 ((Suppl 1)) S-108 , (Abstract 197)
  PubMed
• 22 Morini E, Frisina N, Campennì A, Calbo L, Calbo E, Trimarchi F, Benvenga S. Association between primary hyperparathyroidism (p-hyperPTH) and nodular toxic goiter (NTG): a prospective study at an outpatient service for osteoporosis.  European Thyroid Association, Napoli, September 2-6. 2006;  , (Abstract P 132)
  PubMedGoogle Scholar
• 23 Lim CY, Yun J-S, Lee J, Nam K-H, Chung WY, Park CS. Percutaneous ethanol injection therapy for locally recurrent papillary thyroid carcinoma.  Thyroid. 2007;  17 347-350
  CrossrefPubMedGoogle Scholar
• 24 Rago T, Santini F, Scutari M, Pinchera A, Vitti P. Elastography: new developments in ultrasound for predicting malignancy in thyroid nodules.  J Endocrinol Metab. 2007;  92 2917-2922
  CrossrefPubMedGoogle Scholar
• 25 Bae U, Dighe M, Dubinsky T, Minoshima S, Shamdsani V, Kim Y. Ultrasound thyroid elastography using carotid artery pulasation: preliminary study.  J Ultrasound Med. 2007;  26 797-805
  PubMedGoogle Scholar
• 26 Lyshchik A, Higashi T, Asato R. et al . Thyroid gland tumor diagnosis at US elastography.  Radiology. 2005;  237 202-211
  CrossrefPubMedGoogle Scholar
• 27 Ueno E, Ito A. Diagnosis of breast cancer by elasticity imaging.  Eizo Joho Medical. 2004;  36 2-6
  PubMedGoogle Scholar
• 28 Sarlis NJ, Gourgiotis L. Miscellaneous tumors of the thyroid. In: Braverman LE, Utiger RD (ed). The Werner & Ingbar's The Thyroid: a clinical and fundamental text. Philadelphia: Lippincott, Williams & Wilikins 2005: 989-995
  Google Scholar
• 29 Schlumberger M, Pacini F. Unusual thyroid tumors. In: Schlumberger M, Pacini F (ed). Paris: Nucleéon 1999: 301-305
  Google Scholar
• 30 Iesalnieks I, Trupka A, Raab M. et al . Renal cell carcinoma metastases to the thyroid gland - 8 cases reported.  Thyroid. 2007;  17 49-52
  CrossrefPubMedGoogle Scholar
• 31 Yano Y, Nagakama M, Sugino K, Ito K, Kameyama K, Ito K. Paraganglioma of the thyroid: report of a male case with ultrasonographic imagings, cytologic, histologic, and immunohistochemical features.  Thyroid. 2007;  17 575-578
  CrossrefPubMedGoogle Scholar
• 32 Corrado S, Montanini V, Gaetani C De, Borghi F, Papi G. Primary paraganglioma of the thyroid gland.  J Endocrinol Invest. 2004;  27 788-792
  CrossrefPubMedGoogle Scholar
• 33 Boikos SA, Stratakis CA. Molecular mechanisms of medullary thyroid carcinoma: current approaches in diagnosis and treatment.  Histol Histopathol. 2008;  23 109-116
  PubMedGoogle Scholar
• 34 Vantyghem MC, Daniel T, Marcelli-Tourvielle S. et al . Calcitonin levels do not decrease with weaning in chronic alcoholism.  Thyroid. 2007;  17 213-217
  CrossrefPubMedGoogle Scholar

Correspondence

Prof. S. Benvenga

Programma di Endocrinologia Molecolare Clinica

c/o UOC di Endocrinologia

AOU Policlinico G. Martino

Padiglione H

4 piano

98125 Messina

Italy

Phone: +39/090/221 71 07

Fax: +39/090/221 35 17

Email: s.benvenga@me.nettuno.it

Email: sbenvenga@unime.it